نتائج البحث

Advances on immunotherapy for osteosarcoma.

• Authors : Yu, Shengnan¹ (AUTHOR); Yao, Xudong² (AUTHOR)

• Source: Molecular Cancer. 9/9/2024, Vol. 23 Issue 1, p1-21. 21p.

تفاصيل العنوان

NDR1 mediates PD-L1 deubiquitination to promote prostate cancer immune escape via USP10.

• Authors : Fu, Meiling¹ (AUTHOR); Li, Jinxin² (AUTHOR); Xuan, Zuodong¹ (AUTHOR)

• Source: Cell Communication & Signaling. 9/3/2024, Vol. 22 Issue 1, p1-16. 16p.

تفاصيل العنوان

Impact of pretreatment body mass index on clinical outcomes in patients with metastatic renal cell carcinoma receiving first-line immune checkpoint inhibitor-based therapy: A systematic review and meta-analysis.

• Authors : Kunwoo Lee¹; Jiwoong Yu²; Wan Song²

• Source: Investigative & Clinical Urology. Sep2024, Vol. 65 Issue 5, p423-434. 24p.

تفاصيل العنوان

APOL6 predicts immunotherapy efficacy of bladder cancer by ferroptosis.

• Authors : Fan, Zhiwei^1,2,3 (AUTHOR); Liu, Yiting^1,2,4 (AUTHOR); Wang, Xuehai² (AUTHOR)

• Source: BMC Cancer. 8/26/2024, Vol. 24 Issue 1, p1-18. 18p.

تفاصيل العنوان

Spatial computational modelling illuminates the role of the tumour microenvironment for treating glioblastoma with immunotherapies.

• Authors : Mongeon, Blanche^1,2; Hébert-Doutreloux, Julien¹; Surendran, Anudeep^3,4

• Source: NPJ Systems Biology & Applications. 8/18/2024, Vol. 10 Issue 1, p1-13. 13p.

تفاصيل العنوان

Strategies to enhance the therapeutic efficacy of anti-PD-1 antibody, anti-PD-L1 antibody and anti-CTLA-4 antibody in cancer therapy.

• Authors : Su, Xin^1,2 (AUTHOR); Li, Jian^1,2 (AUTHOR); Xu, Xiao^1,2 (AUTHOR)

• Source: Journal of Translational Medicine. 8/9/2024, Vol. 22 Issue 1, p1-43. 43p.

تفاصيل العنوان

Generalized Eruptive Keratoacanthoma (GEKA) after Pfizer mRNABNT162b2 (Comirnaty ®) COVID-19 Vaccination Successfully Treated with Cemiplimab.

• Authors : Ilaria, Proietti¹ (AUTHOR) ; Nevena, Skroza¹ (AUTHOR) ; Ersilia, Tolino¹ (AUTHOR)

Subjects: *BOOSTER vaccines; *IMMUNE checkpoint inhibitors; *COVID-19 vaccines

• Source: Viruses (1999-4915). Aug2024, Vol. 16 Issue 8, p1260. 5p.

تفاصيل العنوان

Potential mechanisms of cancer stem‐like progenitor T‐cell bio‐behaviours.

• Authors : Ni, Ling¹ (AUTHOR)

• Source: Clinical & Translational Medicine. Aug2024, Vol. 14 Issue 8, p1-14. 14p.

تفاصيل العنوان

Peripheral immune biomarkers for immune checkpoint inhibition of solid tumours.

• Authors : Goswami, Meghali¹ (AUTHOR); Toney, Nicole J.¹ (AUTHOR); Pitts, Stephanie C.¹ (AUTHOR)

• Source: Clinical & Translational Medicine. Aug2024, Vol. 14 Issue 8, p1-20. 20p.

تفاصيل العنوان

Effects of KRAS, STK11, KEAP1, and TP53 mutations on the clinical outcomes of immune checkpoint inhibitors among patients with lung adenocarcinoma.

• Authors : Liang, Yao¹ (AUTHOR) ; Maeda, Osamu¹ (AUTHOR); Kondo, Chiaki¹ (AUTHOR)

Subjects: *LUNGS; *IMMUNE checkpoint inhibitors; *RAS oncogenes

• Source: PLoS ONE. 7/22/2024, Vol. 19 Issue 7, p1-15. 15p.

تفاصيل العنوان